XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive Loss
Total
Balance at the beginning at Dec. 31, 2022 $ 18 $ 577,603 $ (19,090) $ (3,159) $ 555,372
Balance at the beginning (in shares) at Dec. 31, 2022 176,007,184        
Changes in stockholder's equity          
Net loss     (19,158)   (19,158)
Stock options exercised   150     150
Stock options exercised (in shares) 1,679,954        
Stock-based compensation expense   2,222     2,222
Unrealized gain (loss) on marketable securities       885 885
Balance at the end at Mar. 31, 2023 $ 18 579,975 (38,248) (2,274) 539,471
Balance at the end (in shares) at Mar. 31, 2023 177,687,138        
Balance at the beginning at Dec. 31, 2023 $ 18 588,515 (84,639) (559) 503,335
Balance at the beginning (in shares) at Dec. 31, 2023 179,010,884        
Changes in stockholder's equity          
Net loss     (21,207)   (21,207)
Withholding of employee taxes related to stock-based compensation   (169)     (169)
Shares of common stock issued for vested RSUs (in shares) 161,995        
Stock options exercised   97     $ 97
Stock options exercised (in shares) 2,360,316        
Shares of common stock repurchased (3,183,638)       (3,183,638)
Repurchase and retirement of shares of common stock   (4,963)     $ (4,963)
Stock-based compensation expense   2,863     2,863
Unrealized gain (loss) on marketable securities       (579) (579)
Balance at the end at Mar. 31, 2024 $ 18 $ 586,343 $ (105,846) $ (1,138) $ 479,377
Balance at the end (in shares) at Mar. 31, 2024 178,349,557